4//SEC Filing
Meyers Michael L. 4
Accession 0001562180-19-000853
CIK 0001395937other
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 4:27 PM ET
Size
7.5 KB
Accession
0001562180-19-000853
Insider Transaction Report
Form 4
Meyers Michael L.
SVP, Chief Development Officer
Transactions
- Other
Common Stock
2019-01-31$4.76/sh+3,720$17,707→ 6,118 total - Award
Stock Option (Right to Buy)
2019-02-06+104,325→ 104,325 totalExercise: $6.38Exp: 2029-02-06→ Common Stock (104,325 underlying)
Footnotes (2)
- [F1]The Reporting Person is voluntarily filing this Form 4 to report the acquisition of 3,720 shares by the Reporting Person on 01/31/2019 pursuant to the Issuer's Employee Stock Purchase Plan.
- [F2]The securities awarded on 02/06/2019 were in the form of stock options issued pursuant to the Syndax Pharmaceuticals, Inc. 2015 Omnibus Incentive Plan. Options to purchase 50,825 shares of common stock shall vest in 48 successive equal monthly installments measured from 02/06/2019. Options to purchase 53,500 shares of common stock shall vest periodically upon the Issuer achieving certain milestones.
Documents
Issuer
Syndax Pharmaceuticals Inc
CIK 0001395937
Entity typeother
Related Parties
1- filerCIK 0001664204
Filing Metadata
- Form type
- 4
- Filed
- Feb 7, 7:00 PM ET
- Accepted
- Feb 8, 4:27 PM ET
- Size
- 7.5 KB